Cargando…
The CD73/Ado System—A New Player in RT Induced Adverse Late Effects
Radiotherapy (RT) is a central component of standard treatment for many cancer patients. RT alone or in multimodal treatment strategies has a documented contribution to enhanced local control and overall survival of cancer patients, and cancer cure. Clinical RT aims at maximizing tumor control, whil...
Autores principales: | de Leve, Simone, Wirsdörfer, Florian, Jendrossek, Verena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827091/ https://www.ncbi.nlm.nih.gov/pubmed/31623231 http://dx.doi.org/10.3390/cancers11101578 |
Ejemplares similares
-
Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578
por: de Leve, Simone, et al.
Publicado: (2019) -
Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
por: de Leve, Simone, et al.
Publicado: (2019) -
The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung
por: Wirsdörfer, Florian, et al.
Publicado: (2016) -
Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?
por: Wirsdörfer, Florian, et al.
Publicado: (2018) -
Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cells
por: Wirsdörfer, Florian, et al.
Publicado: (2014)